| Literature DB >> 27471459 |
Chenyi Chen1, Chia-Chien Liu2, Pei-Yuan Weng3, Yawei Cheng4.
Abstract
Although the general consensus holds that emotional perception is impaired in patients with schizophrenia, the extent to which neural processing of emotional voices is altered in schizophrenia remains to be determined. This study enrolled 30 patients with chronic schizophrenia and 30 controls and measured their mismatch negativity (MMN), a component of auditory event-related potentials (ERP). In a passive oddball paradigm, happily or angrily spoken deviant syllables dada were randomly presented within a train of emotionally neutral standard syllables. Results showed that MMN in response to angry syllables and angry-derived non-vocal sounds was significantly decreased in individuals with schizophrenia. P3a to angry syllables showed stronger amplitudes but longer latencies. Weaker MMN amplitudes were associated with more positive symptoms of schizophrenia. Receiver operator characteristic analysis revealed that angry MMN, angry-derived MMN, and angry P3a could help predict whether someone had received a clinical diagnosis of schizophrenia. The findings suggested general impairments of voice perception and acoustic discrimination in patients with chronic schizophrenia. The emotional salience processing of voices showed an atypical fashion at the preattentive level, being associated with positive symptoms in schizophrenia.Entities:
Keywords: emotional salience; mismatch negativity; receiver operator characteristic; schizophrenia; voices
Year: 2016 PMID: 27471459 PMCID: PMC4945630 DOI: 10.3389/fnhum.2016.00362
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Demographic and clinical variables related to study participants.
| Schizophrenia | Controls | ||||
|---|---|---|---|---|---|
| Mean | Mean | ||||
| Age (yrs) | 39.8 | 4.8 | 36.5 | 4.9 | 0.14 |
| Education (yrs) | 11.8 | 2.6 | 14.0 | 3.4 | 0.006 |
| Duration of illness (yrs) | 14.6 | 9.1 | |||
| PANSS (range) | |||||
| Positive scale (8 ~ 21) | 14.1 | 3.7 | |||
| Negative scale (7 ~ 24) | 14.2 | 3.8 | |||
| General Psychopathology (20 ~ 43) | 31.4 | 6.1 | |||
Handedness and medications for each individual with schizophrenia.
| Subject | Right Handedness | Drug | Dose | Dose No. |
|---|---|---|---|---|
| F01 | 90% | Risdone | 2 mg | 1 |
| Clonopam | 0.5 mg | 0.25 | ||
| Minlife (Loratadine) | 10 mg | 1 | ||
| F02 | 90% | Xanax (Alprazolam) | 0.5 mg | 1+0.5 |
| Clopine | 100 mg | 0.5+1 | ||
| F03 | 80% | Bipiden (Biperiden) | 2 mg | 0.5 |
| Polupi | 50 mg | 1 | ||
| Risdone (Risperidone) | 2 mg | 1 | ||
| Januvia F.C | 100 mg | 1 | ||
| Cipram (Citalopram) | 20 mg | 0.5 | ||
| Eltroxin (Thyroxine Sodium) | 100 mg | 1.5 | ||
| Imovane (Zopiclone) | 7.5 mg | 0.5 | ||
| F04 | 85% | Risdone | 2 mg | 1 |
| Zolman.F.C | 10 mg | 2 | ||
| Bipiden | 2 mg | 1 | ||
| Clonopam | 0.5 mg | 1 | ||
| venforspine | 75 mg | 1 | ||
| Rivotril | 2 mg | 1 | ||
| Etomine | 40 mg | 2 | ||
| F05 | 90% | Juxac (Fluoxetine) | 20 mg | 1 |
| Olanzapine | 5 mg | 1 | ||
| Delopic | 20 mg | 1 | ||
| F06 | 90% | Juxac (Fluoxetine) | 20 mg | |
| Mesyrel (Trazodone HCl) | 50 mg | 1 | ||
| Clonopam (Clonazepam) | 0.5 mg | 0.5 | ||
| Abilify (Aripiprazole) | 10 mg | 1 | ||
| Zolman | 10 mg | 1 | ||
| F07 | 85% | |||
| F08 | 90% | |||
| F09 | 100% | Fluanxol | 3 mg | 1 |
| F10 | 100% | Clopine | 100 mg | 2 |
| F11 | 100% | Clopine | 100 mg | 1 |
| Trynol S.C | 25 mg | 1 | ||
| F12 | 100% | Ativan (Lorazepam) | 0.5 mg | 1 |
| Dupin (Diazepam) | 5 mg | 0.5 | ||
| Inderal (Propranolol) | 10 mg | 1 | ||
| Zyprexa Zydis | 5 mg | 1 | ||
| F13 | 90% | Xanax | 0.5 mg | 1 |
| Fluanxol | 3 mg | 2 | ||
| Etumine | 40 mg | 1 | ||
| Clonopam | 0.5 mg | 1 | ||
| Rivotril | 2 mg | 0.5 | ||
| Bipiden | 2 mg | 1 | ||
| F14 | 85% | Clopine | 100 mg | 1.5 |
| Semi-Nax | 10 mg | 1 | ||
| Clonopam | 0.5 mg | 0.5 | ||
| Juxac | 20 mg | 1 | ||
| F15 | 65% | Semi-Nax | 10 mg | 1 |
| Xanax | 0.5 mg | 0.5 | ||
| Zyprexa Zydis | 5 mg | 1.5 | ||
| F16 | 75% | Xanax | 0.5 mg | 1 |
| Modipan | 2 mg | 1 | ||
| Dogmatyl | 200 mg | 3 | ||
| Efexor | 37.5 mg | 1 | ||
| Clonopam | 0.5 mg | 0.5 | ||
| Morefine | 100 mg | 1 | ||
| Parlodel | 2.5 mg | 0.5 | ||
| F17 | 100% | Abilify | 10 mg | 0.5 |
| Silence | 1 mg | 1 | ||
| F18 | 80% | Bipiden | 2 | 1 |
| Flurazin | 5 | 1 | ||
| Juxac | 20 | 1 | ||
| Lexotan | 3 | 0.25 | ||
| F19 | 100% | Abilify | 10 | 1.5 |
| Rivotril | 2 | 0.5 | ||
| Bipiden | 2 | 0.5 | ||
| F20 | 85% | Semi-Nax | 10 mg | 0.5 |
| Clonopam | 0.5 mg | 0.5 | ||
| Risdone | 2 | 1 | ||
| F21 | 90% | |||
| M01 | 85% | Fluanxol | 3 mg | 1 |
| Silence | 1 mg | 1 | ||
| Bipiden | 2 mg | 1 | ||
| Etumine | 40 mg | 1 | ||
| Clonopam | 0.5 mg | 1 | ||
| Fluanxol | 20 mg/1 ml | 1 | ||
| Juxac | 20 mg | 1 | ||
| M02 | 100% | Clopine (Clozapine) | 100 mg | 2 |
| Crestor | 10 mg | 1 | ||
| M03 | 100% | Clopine | 100 mg | 1 |
| Clonopam | 0.5 mg | 0.5 | ||
| Juxac | 20 mg | 1 | ||
| Semi-nax | 100 mg/tab | 1 | ||
| Xanax | 0.5 mg | 0.5 | ||
| Vitacome | 1 | |||
| Lipanthyl | 200 mg | 1 | ||
| M04 | 85% | |||
| M05 | 80% | Dogmatyl (Sulpiride) | 200 mg | 1 |
| Genbou F.C (Fluvoxamine) | 50 mg | 1 | ||
| Zyprexa Zydis | 5 mg | 1.5 | ||
| M06 | 90% | |||
| M07 | 90% | Dogmatyl | 200 mg | 2 |
| Bipiden | 2 mg | 1.5 | ||
| M08 | 90% | Bipiden | 2 mg | 1 |
| Zolman F.C | 10 mg | 1 | ||
| Eurodin | 2 mg | 1 | ||
| Clonopam | 0.5 mg | 1 | ||
| Dogmatyl | 200 mg | 3 | ||
| M09 | 85% | Bipiden | 2 mg | 1 |
| Dogmatyl | 2 mg | 1 |
Mean amplitude and latencies of MMN to emotional syllables and non-vocal sounds within a time window of 150 to 350 ms at frontal electrodes in individuals with schizophrenia and controls (Mean ± SD).
| Schizophrenia | Controls | |||||
|---|---|---|---|---|---|---|
| Amplitudes (μV) | Latency (ms) | Amplitudes (μV) | Latency (ms) | |||
| Emotional syllables | Angry | F3 | -1.77 ± 1.20 | 245.27 ± 57.25 | -2.55 ± 1.12 | 251.00 ± 51.81 |
| Fz | -1.94 ± 1.23 | 239.33 ± 54.31 | -2.69 ± 1.19 | 247.93 ± 55.60 | ||
| F4 | -1.85 ± 1.30 | 244.87 ± 52.14 | -2.58 ± 1.02 | 256.27 ± 55.67 | ||
| Happy | F3 | -1.04 ± 0.94 | 245.33 ± 49.34 | -1.33 ± 0.68 | 259.33 ± 51.61 | |
| Fz | -1.17 ± 1.18 | 248.93 ± 51.43 | -1.51 ± 0.76 | 255.47 ± 51.24 | ||
| F4 | -1.01 ± 1.10 | 244.21 ± 40.41 | -1.45 ± 0.75 | 258.33 ± 47.54 | ||
| Non-vocal sounds | Angry-derived | F3 | -1.87 ± 1.15 | 245.13 ± 47.81 | -2.65 ± 1.16 | 251.13 ± 36.40 |
| Fz | -2.06 ± 1.14 | 245.00 ± 47.28 | -2.89 ± 1.18 | 249.00 ± 37.76 | ||
| F4 | -2.00 ± 1.00 | 237.93 ± 47.46 | -2.73 ± 1.20 | 248.07 ± 37.65 | ||
| Happy-derived | F3 | -0.75 ± 0.76 | 233.67 ± 54.83 | -0.76 ± 0.53 | 262.13 ± 56.30 | |
| Fz | -0.64 ± 0.85 | 241.87 ± 50.72 | -0.89 ± 0.57 | 261.60 ± 54.61 | ||
| F4 | 0.67 ± 0.91 | 251.47 ± 56.04 | -0.79 ± 0.55 | 253.07 ± 55.45 | ||
Mean amplitude and latencies of P3a to emotional syllables and non-vocal sounds within a time window of 250 to 450 ms at frontal electrodes in individuals with schizophrenia and controls (Mean ± SD).
| Schizophrenia | Controls | |||||
|---|---|---|---|---|---|---|
| Amplitudes (μV) | Latency (ms) | Amplitudes (μV) | Latency (ms) | |||
| Emotional syllables | Angry | F3 | 2.03 ± 1.28 | 376.87 ± 46.66 | 1.22 ± 1.44 | 362.67 ± 51.43 |
| Fz | 2.09 ± 1.54 | 378.53 ± 47.61 | 1.41 ± 1.45 | 354.87 ± 48.45 | ||
| F4 | 1.90 ± 1.51 | 384.73 ± 46.95 | 1.20 ± 1.18 | 350.13 ± 49.48 | ||
| Happy | F3 | 1.36 ± 1.78 | 341.40 ± 45.50 | 1.19 ± 1.04 | 346.27 ± 47.25 | |
| Fz | 1.43 ± 1.41 | 340.53 ± 47.29 | 1.24 ± 1.10 | 358.27 ± 46.95 | ||
| F4 | 1.30 ± 1.37 | 346.67 ± 47.87 | 1.08 ± 0.90 | 357.93 ± 50.15 | ||
| Non-vocal sounds | Angry-derived | F3 | 0.82 ± 1.13 | 363.73 ± 45.60 | 1.28 ± 1.24 | 366.67 ± 29.31 |
| Fz | 0.96 ± 1.19 | 356.20 ± 50.27 | 1.41 ± 1.38 | 366.93 ± 27.82 | ||
| F4 | 0.73 ± 1.03 | 365.73 ± 51.01 | 1.32 ± 1.20 | 361.60 ± 25.85 | ||
| Happy-derived | F3 | 0.93 ± 0.95 | 338.93 ± 52.45 | 0.69 ± 0.69 | 349.33 ± 56.44 | |
| Fz | 1.16 ± 1.33 | 334.20 ± 46.04 | 0.77 ± 0.68 | 340.67 ± 59.35 | ||
| F4 | 1.08 ± 1.22 | 338.47 ± 45.90 | 0.79 ± 0.63 | 348.07 ± 53.53 | ||
The correlation analysis between PANSS (positive, negative, and general psychopathology) and angry MMN/P3a amplitudes, including the correlation coefficients (ρ) and P values corrected for multiple comparisons.
| F3 | Fz | F4 | C3 | Cz | C4 | |
|---|---|---|---|---|---|---|
| Positive scale | ||||||
| ρ | -0.41 | -0.36 | -0.33 | -0.52* | -0.42 | -0.51 |
| 0.375 | 0.630 | 0.075 | 0.003 | 0.330 | 0.060 | |
| Negative scale | ||||||
| ρ | -0.30 | -0.05 | 0.04 | -0.18 | -0.13 | -0.20 |
| 0.111 | 0.794 | 0.828 | 0.347 | 0.491 | 0.288 | |
| General psychopathology | ||||||
| ρ | -0.17 | -0.07 | 0.03 | -0.27 | -0.17 | -0.26 |
| 0.357 | 0.718 | 0.890 | 0.145 | 0.378 | 0.169 | |
| Positive scale | ||||||
| ρ | 0.01 | -0.16 | -0.22 | -0.01 | 0.06 | -0.12 |
| 0.953 | 0.452 | 0.274 | 0.945 | 0.767 | 0.545 | |
| Negative scale | ||||||
| ρ | 0.30 | 0.06 | -0.11 | -0.01 | 0.05 | -0.17 |
| 0.130 | 0.773 | 0.596 | 0.975 | 0.824 | 0.401 | |
| General psychopathology | ||||||
| ρ | 0.09 | -0.12 | -0.21 | 0.07 | 0.05 | -0.11 |
| 0.640 | 0.553 | 0.290 | 0.749 | 0.793 | 0.581 |